Keyphrases
AAV2
66%
Anti-tumor Response
66%
Antibody Therapeutics
66%
Antigen Presentation
93%
Antigen Targeting
66%
Antigen-specific
30%
Apoptosis
66%
Babesia Bovis
66%
Bak Activation
66%
Bovine Leukocyte Antigen (BoLA)
66%
Candidate Selection Method
66%
Cytolytic T Cells
66%
Dephosphorylation
40%
Derived Peptide
80%
E2F Transcription Factor 1 (E2F1)
50%
Epitope
66%
Human Tissue
66%
Hypoxia
66%
Immunogenic
80%
In Cancer
66%
In Vivo Genome Editing
44%
Influenza
66%
Influenza Virus
26%
Interactome
66%
Long Non-coding RNA (LncRNA)
80%
Major Histocompatibility Complex
66%
MARS®
66%
MHC Class I
26%
MHC Class II
80%
Mitochondrial Apoptosis
26%
Non-canonical
66%
Non-coding RNA (ncRNA)
66%
Peptide Antigen
27%
Peptide Sequencing
26%
Phosphorylation
26%
Protein Arginine Methyltransferase 5 (PRMT5)
50%
PTPN5
26%
Puerto Rico
26%
Qa-1
40%
S. Bovis
66%
SaCas9
66%
Specific T Cells
26%
T Cell Response
66%
Target Discovery
66%
TCR-like Antibody
66%
Tuberculosis Vaccine
66%
Tumor Cells
39%
Tumor Immune Evasion
66%
Tyrosine Phosphorylation
66%
Viral Epitopes
26%
Immunology and Microbiology
Adeno-Associated Virus
33%
Adoptive Immunity
11%
Amination
22%
Amino Acid
11%
Amino Terminal Sequence
16%
Antigen Presentation
22%
Antigen Specificity
11%
Antiviral Immunity
11%
Autoimmunity
11%
Babesia bovis
66%
BCG Vaccine
66%
Cell Death
16%
Cell Survival
16%
Codon
11%
Cytokine
11%
Cytolysis
11%
Cytotoxic T-Cell
44%
Dephosphorylation
66%
Epitope
88%
Erythrocyte
16%
Human Leukocyte Antigen
11%
Human Tissue
66%
Immunogenicity
11%
Immunopeptidomics
11%
Immunosurveillance
11%
In Vitro
16%
In Vitro Gene Transfer
16%
Influenza
66%
Influenzavirus A
22%
interferon
66%
Liver Tissue
11%
Major Histocompatibility Complex
66%
Mediator
16%
Memory B Cell
11%
Peptide Library
11%
Peptides
88%
Post-Translational Modification
27%
Programmed Cell Death
66%
Protein Expression
16%
Protein Motif
11%
Reading Frame
11%
RNAI
16%
Synthetic Vaccine
16%
T Cell
77%
T Cell Activation
11%
T Cell Receptor
66%
Therapeutic Antibodies
66%
Translation Initiation
11%
Tumor Spheroid
11%
Tyrosine
66%
Biochemistry, Genetics and Molecular Biology
Amination
22%
Antigen Presentation
100%
Antigen Specificity
11%
Autophagy
44%
CD8
11%
Cell Death
16%
Cell Survival
16%
Dendritic Cell
11%
Dephosphorylation
66%
E2F1
33%
Gene Expression
11%
Genome Sequencing
33%
Human Leukocyte Antigen
33%
Immunopeptidomics
22%
Liquid Chromatography-Mass Spectrometry
22%
Long Non-Coding RNA
100%
Major Histocompatibility Complex, Class I-Related
22%
Mediator
16%
Methylation
11%
MHC Class I
33%
Mitochondrial Respiration
22%
N-Terminus
16%
Open Reading Frame
11%
Oxygenation
22%
Peptide Library
33%
Peptide Sequence
66%
Posttranslational Modification
16%
Programmed Cell Death
66%
Protein Arginine Methyltransferase 5
11%
Protein Expression
16%
Receptor Tyrosine Phosphatase
16%
Retention Time
33%
RNA Gene
11%
RNA Sequence
33%
RNAI
16%
Small Interfering RNA
16%
T Cell
55%
Transcription
11%
Tumor Escape
66%
Tumor Progression
11%
Tyrosine
66%
Unfolded Protein Response
22%
Virus Vector
11%
